We are delighted to announce the launch of the Annual Review of Cancer Biology, the 47th in our collection of highly cited review journals. It seems appropriate to focus on Cancer Research, a field that is deeply linked to the investigation of central themes in the life sciences, during our 85th year of service to the research community. It is also a natural fit for the interdisciplinary coverage of our portfolio of existing journals.
Co-Editors Dr. Tyler Jacks (Director of the Koch Institute for Integrative Cancer Research at MIT) and Dr. Charles L. Sawyers (Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering) said:
“Cancer Biology covers a wide range of disciplines that are converging to provide a deep understanding of the cancer cell and the various biological and physiological processes that contribute to tumor initiation and progression. These advances—coupled with the application of an increasing array of powerful technologies—have paved the way for the development of numerous new medicines that are greatly benefiting cancer patients.”
Their introduction to the first volume summarizes the goals of this new publication. The first volume of the Annual Review of Cancer Biology contains more than twenty reviews that address the basic mechanisms of cancer development and the translation to therapeutic strategies today and in the future. The journal scope includes three broad themes to cover a broad spectrum of the rapidly moving cancer biology field: Cancer Cell Biology, Tumorigenesis and Cancer Progression, and Translational Cancer Science.
The first volume also contains a review by Dr. Harold Varmus (Weill Cornell Medical College) entitled How Tumor Virology Evolved into Cancer Biology and Transformed Oncology (published Open Access). Dr. Sawyers expanded, “Cancer research has become deeply linked to investigation of the central themes in the life sciences. Dr. Varmus’s work has been important to the evolution of our interdisciplinary science.”
Dr. Jacks is also involved in the Cancer Moonshot, where he serves as the Scientific Panel Co-Chair. Former US Vice-President Joe Biden updated attendees of SXSW on March 12th with progress of the Moonshot. To learn more about Dr. Jacks’ dedication to cancer research, check out his presentation at TEDxCambridge: Tyler Jacks (Life lessons from 34 years of fighting cancer.)
Dr. Sawyers is involved in Stand up to Cancer, a groundbreaking initiative created to accelerate innovative cancer research and quickly provide patients with access to new therapies in the hope of saving lives. He is the co-leader of the Scientific Research Dream Team on Precision Therapy for Advanced Prostate Cancer.
This journal is now available online (March 6th, 2017). If you are a journalist, writer, or blogger who wants access to this and/or other Annual Reviews journals, please email us. The official Press Release is available in our Press Center.
Annual Reviews is a nonprofit publisher dedicated to synthesizing and integrating knowledge for the progress of science and the benefit of society.